BMY

Bristol-Myers Squibb
D

BMY

Arincen68/100B

Bristol-Myers Squibb cash on hand 1987–2026

Bristol-Myers Squibb had 12.58B USD in cash and short-term investments on 30 September 2026, down 23.8% on a year before. At the end of fiscal year 2025 it had 10.67B USD.

Last updated 12 Nov 2026 · Next report 4 Feb 2027

Cash on hand

Growth

Fiscal yearPeriod endingCash on handGrowthTotal debtNet cash
Latest quarter30 Sept 202612.58B-23.76%44.81B-32.23B
FY202531 Dec 202510.67B-1.71%47.14B-36.47B
FY202431 Dec 202410.86B-11.57%51.20B-40.34B
FY202331 Dec 202312.28B+32.71%41.46B-29.18B
FY202231 Dec 20229.25B-46.27%40.72B-31.46B
FY202131 Dec 202117.22B+4.69%45.60B-28.38B
FY202031 Dec 202016.45B+6.87%51.67B-35.22B
FY201931 Dec 201915.39B+75.74%47.54B-32.15B
FY201831 Dec 20188.76B+28.58%7.35B1.41B
FY201731 Dec 20176.81B+7.28%7.96B-1.15B
FY201631 Dec 20166.35B+48.71%6.71B-358.00M
FY201531 Dec 20154.27B-42.57%6.69B-2.42B
FY201431 Dec 20147.44B+64.31%7.83B-397.00M
FY201331 Dec 20134.53B+59.95%8.34B-3.82B
FY201231 Dec 20122.83B-67.61%7.39B-4.57B
FY201131 Dec 20118.73B+19.61%5.49B3.24B
FY201031 Dec 20107.30B-14.25%5.45B1.86B
FY200931 Dec 20098.51B+3.01%6.36B2.15B
FY200831 Dec 20088.27B+271.46%6.74B1.53B
FY200731 Dec 20072.23B-44.56%6.27B-4.05B
FY200631 Dec 20064.01B-30.80%7.44B-3.42B
FY200531 Dec 20055.80B-22.41%8.60B-2.80B
FY200431 Dec 20047.47B+34.38%10.35B-2.87B
FY200331 Dec 20035.56B+39.43%8.75B-3.19B
FY200231 Dec 20023.99B-29.45%7.64B-3.65B
FY200131 Dec 20015.65B+67.03%6.41B-757.00M
FY200031 Dec 20003.39B+14.47%1.50B1.89B
FY199931 Dec 19992.96B+31.77%1.77B1.18B
FY199831 Dec 19982.24B+54.12%1.85B398.00M
FY199731 Dec 19971.46B-13.38%1.82B-366.00M
FY199631 Dec 19961.68B+2.19%1.48B202.00M
FY199531 Dec 19951.65B+0.18%1.21B435.00M
FY199431 Dec 19941.64B-32.18%1.37B273.00M
FY199331 Dec 19932.42B+13.29%765.00M1.66B
FY199231 Dec 19922.14B+48.92%551.00M1.59B
FY199131 Dec 19911.44B+140.77%688.00M747.00M
FY199031 Dec 1990596.00M+16.86%628.00M-32.00M
FY198931 Dec 1989510.00M-79.70%518.00M-8.00M
FY198831 Dec 19882.51B+7.03%963.00M1.55B
FY198731 Dec 19872.35B—694.00M1.65B

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Total debt,Free cash flow,Stock buybacks,Balance sheet

Common questions about Bristol-Myers Squibb's cash

Source: Financial Modeling PrepVerified against SEC filings